Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization

Filters

#	Name	Market cap	Price	Price change %
1	1 Amgen AMGN $180B	$180B	$334.85	+0.21%
2	2 Gilead Sciences GILD $95.9B	$95.9B	$77.01	+0.64%
3	3 Moderna MRNA $46.8B	$46.8B	$122.11	+0.58%
4	4 Biogen BIIB $30.7B	$30.7B	$211.17	-7.15%
5	5 Neurocrine Biosciences NBIX $14.8B	$14.8B	$146.80	+0.48%
6	6 Bio-Techne TECH $12.7B	$12.7B	$80.60	+2.45%
7	7 Vaxcyte PCVX $9.14B	$9.14B	$84.05	+0.48%
8	8 Repligen RGEN $7.87B	$7.87B	$140.79	+6.37%
9	9 Revolution Medicines RVMD $7.66B	$7.66B	$46.44	+1.93%
10	10 Halozyme HALO $7.16B	$7.16B	$56.23	+0.46%
11	11 Exelixis EXEL $6.81B	$6.81B	$23.39	+1.87%
12	12 Krystal Biotech KRYS $6.1B	$6.1B	$213.66	+1.41%
13	13 CRISPR Therapeutics CRSP $4.92B	$4.92B	$57.92	+0.61%
14	14 Immunovant IMVT $4.25B	$4.25B	$29.10	+4.68%
15	15 ImmunityBio IBRX $3.88B	$3.88B	$5.61	+3.1%
16	16 Arcellx ACLX $3.45B	$3.45B	$64.41	+2.74%
17	17 Denali Therapeutics DNLI $3.44B	$3.44B	$24.10	+0.04%
18	18 Twist Bioscience TWST $3.38B	$3.38B	$58.08	+0.99%
19	19 ADMA Biologics ADMA $3.05B	$3.05B	$13.16	+0.61%
20	20 SpringWorks Therapeutics SWTX $2.82B	$2.82B	$38.04	+3.17%
21	21 Apogee Therapeutics APGE $2.82B	$2.82B	$49.95	+2.65%
22	22 Kymera Therapeutics KYMR $2.73B	$2.73B	$44.54	+1.14%
23	23 Beam Therapeutics BEAM $2.73B	$2.73B	$33.14	+3.02%
24	24 Iovance Biotherapeutics IOVA $2.59B	$2.59B	$9.25	-1.4%
25	25 Vericel Corp VCEL $2.54B	$2.54B	$52.32	+1.2%